These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 20047197

  • 1. Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease.
    Haas MJ, Mooradian AD.
    Diabetes Metab Res Rev; 2010 Feb; 26(2):90-9. PubMed ID: 20047197
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The significance of plasma high density lipoprotein cholesterol (hdlc).
    Gupta S, Rajagopal G.
    Nepal Med Coll J; 2007 Sep; 9(3):212-4. PubMed ID: 18092443
    [Abstract] [Full Text] [Related]

  • 8. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M.
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [Abstract] [Full Text] [Related]

  • 9. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.
    Indian Heart J; 2003 Feb; 55(3):234-40. PubMed ID: 14560932
    [Abstract] [Full Text] [Related]

  • 10. High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies.
    Toth PP.
    Am J Cardiol; 2005 Nov 07; 96(9A):50K-58K; discussion 34K-35K. PubMed ID: 16291015
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
    Chapman MJ.
    Pharmacol Ther; 2006 Sep 07; 111(3):893-908. PubMed ID: 16574234
    [Abstract] [Full Text] [Related]

  • 12. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
    Zambon A, Gervois P, Pauletto P, Fruchart JC, Staels B.
    Arterioscler Thromb Vasc Biol; 2006 May 07; 26(5):977-86. PubMed ID: 16424352
    [Abstract] [Full Text] [Related]

  • 13. Serum high-density lipoprotein cholesterol in male and female Olympic athletes.
    Deshaies Y, Allard C.
    Med Sci Sports Exerc; 1982 May 07; 14(3):207-11. PubMed ID: 7109888
    [Abstract] [Full Text] [Related]

  • 14. Inflammation, high-density lipoprotein and cardiovascular dysfunction.
    Haas MJ, Mooradian AD.
    Curr Opin Infect Dis; 2011 Jun 07; 24(3):265-72. PubMed ID: 21326098
    [Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M.
    J Physiol Pharmacol; 2001 Aug 07; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.
    Eur Cytokine Netw; 2006 Mar 07; 17(1):4-12. PubMed ID: 16613757
    [Abstract] [Full Text] [Related]

  • 17. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC.
    Can J Cardiol; 1990 May 07; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [Abstract] [Full Text] [Related]

  • 18. Low serum high-density lipoprotein cholesterol in obese subjects with normal serum triglycerides: the role of insulin resistance and inflammatory cytokines.
    Mooradian AD, Albert SG, Haas MJ.
    Diabetes Obes Metab; 2007 May 07; 9(3):441-3. PubMed ID: 17391174
    [Abstract] [Full Text] [Related]

  • 19. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
    Lehrke M, Millington SC, Lefterova M, Cumaranatunge RG, Szapary P, Wilensky R, Rader DJ, Lazar MA, Reilly MP.
    J Am Coll Cardiol; 2007 Jan 30; 49(4):442-9. PubMed ID: 17258089
    [Abstract] [Full Text] [Related]

  • 20. High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein.
    Shah PK.
    Am J Cardiol; 2007 Dec 03; 100(11 A):S62-7. PubMed ID: 18047855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.